<DOC>
	<DOCNO>NCT02862899</DOCNO>
	<brief_summary>The investigator study possibility situ heat liquid contain chemotherapy , avoid need external pumping system complexity , associated risk cost . The use heat cable ( prototype hereinafter call Thermowire , make company EFS , charge development ) patent tested pig two study include 15 animal altogether ( 7 heating cable use ) . The aim first study purely safety aspect , efficacy obtain hyperthermia , quality homogeneity hyperthermia effect tissue penetration chemotherapy evaluate second study . The result obtain justify transfer use human context clinical trial obtain CE certification .</brief_summary>
	<brief_title>Use Heating Cable Obtain Hyperthermia During Intraperitoneal Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<criteria>Patients national health insurance cover With scheduled hyperthermic intraperitoneal chemotherapy ( HIPEC ) know peritoneal disease ( primary secondary ) Who provide write consent Persons guardianship Persons 18 year old Pregnant breastfeeding woman Allergy latex Abandon HIPEC follow surgical exploration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>